Heart Attack Peripheral Arterial Disease Stents 
DAIC
FEBRUARY 14, 2024
Encouraged by the early clinical results, Efemoral Medical is now developing an additional device for treating below-the-knee (infrapopliteal) arteries in patients with CLTI. Diseased human arteries are most simply, reliably, and successfully treated with drug-eluting, balloon-expandable stents," said Lewis B.
DAIC
APRIL 5, 2024
With the addition of Shockwave, Johnson & Johnson will expand its MedTech cardiovascular portfolio into two of the highest-growth, innovation-oriented segments of cardiovascular intervention – coronary artery disease (CAD) and peripheral artery disease (PAD).
Dr. Anish Koka
MAY 16, 2023
years of age, P <0.001), cerebral or peripheral artery disease (6.2% There may be no better study to symbolize the dysfunction that has invaded cardiology than the VIRGO trial, a study examining the outcomes of young patients (18-55) presenting to the hospital with a heart attack. years of age versus 59.0±8.4
Expert insights. Personalized for you.
111 
Let's personalize your content